AstraZeneca has opened its first ever clinical pharmacology unit in China, providing support for more trials to be carried out …
Thanks to spiralling costs, increasing regulation and the ever-present threat of litigious action, it is hardly surprising that pharma companies …
Novartis is to open a major, new pharmaceutical research and development centre in China, becoming the first company in the …